Lista de obras - Julien Mazieres - Dominio Público Uruguay

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer.

artículo científico

A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.

artículo científico publicado en 2015

Alternative Processing of the U2 Small Nuclear RNA Produces a 19–22nt Fragment with Relevance for the Detection of Non-Small Cell Lung Cancer in Human Serum ⬇️

artículo científico publicado el 20 de marzo de 2013

An analysis of treatment delays of thoracic cancers: a prospective study

artículo científico publicado en 2013

An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.

artículo científico publicado en 2004

Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting.

artículo científico publicado en 2015

Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.

artículo científico publicado en 2009

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

artículo científico publicado en 2015

Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study.

artículo científico publicado en 2015

Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.

artículo científico publicado en 2005

Bronchial colonisation in patients with lung cancer: a prospective study ⬇️

artículo científico publicado el 25 de octubre de 2012

Bronchoscopic Multimodal Management of Tracheal Neurofibroma

artículo científico publicado en 2016

Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung

artículo científico publicado en 2016

Characteristics of lung cancer in women: importance of hormonal and growth factors.

artículo científico publicado en 2011

Circulating tumor DNA genomics reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant metastatic non-small cell lung cancer patients

artículo científico publicado en 2020

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort

artículo científico publicado en 2015

Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE

artículo científico publicado en 2014

DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients.

artículo científico publicado en 2012

Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.

scientific article published on 11 April 2016

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

artículo científico publicado en 2016

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies

artículo científico publicado en 2016

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma

artículo científico publicado en 2016

Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls

artículo científico

Diagnostic value of bronchoscopy, CT and transbronchial biopsies in diffuse pulmonary lymphangiomatosis: case report and review of the literature.

artículo científico publicado en 2005

Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma.

artículo científico publicado en 2013

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

artículo científico publicado en 2012

Erratum to "Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network" [Lung Cancer, 97 (July 2016), 99-104]

artículo científico publicado en 2016

Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade

artículo científico publicado en 2004

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

artículo científico publicado en 2019

High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.

artículo científico publicado en 2015

Hospital undertaking of patients with a resection of lung cancer

artículo científico publicado en 2012

How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study

artículo científico publicado en 2008

Impact of induction treatment on postoperative complications in the treatment of non-small cell lung cancer.

artículo científico publicado en 2007

Incidence and characteristics of bronchial colonisation in patient with lung cancer: a retrospective study of 388 cases

artículo científico publicado en 2011

Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells.

artículo científico publicado en 2004

Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.

artículo científico publicado en 2004

Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis

artículo científico publicado en 2005

Integration of interventional bronchoscopy in the management of lung cancer

artículo científico publicado en 2015

KRAS and bronchial adenocarcinoma. Between disappointments and hopes

artículo científico publicado en 2015

Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases

artículo científico publicado en 2002

Limited operation for severe multisegmental bilateral bronchiectasis

artículo científico publicado en 2003

Loss of RhoB expression in human lung cancer progression.

artículo científico publicado en 2004

Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1.

artículo científico publicado en 2009

Lung cancer in women and pregnancy: towards a hormonal origin?

artículo científico publicado en 2007

Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives

artículo científico publicado en 2013

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).

artículo científico publicado en 2015

Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP)

artículo científico publicado en 2010

Molecular epidemiology of the lung cancer

artículo científico publicado en 2016

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.

artículo científico publicado en 2016

Nivolumab for treating non-small cell lung cancer.

artículo científico publicado en 2015

Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study).

artículo científico publicado en 2015

Perception of lung cancer among the general population and comparison with other cancers

artículo científico publicado en 2015

Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases.

artículo científico publicado en 2011

Prognostic factors associated with interventional bronchoscopy in lung cancer

artículo científico publicado en 2013

Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer

artículo científico publicado en 2011

RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway

artículo científico publicado en 2016

Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: case report and review of the literature.

artículo científico

Radiofrequency ablation of primary lung cancer: a single centre experience

artículo científico publicado en 2009

Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial

scientific article published on 06 March 2020

RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer.

artículo científico publicado en 2014

RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition

artículo científico publicado en 2015

Routine molecular profiling of patients with NSCLC - Authors' reply

artículo científico publicado en 2016

Specificities of lung adenocarcinoma in women who have never smoked.

artículo científico publicado en 2013

Stenting for superior vena cava obstruction associated with lung cancer: monocentric study

artículo científico publicado en 2009

Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network

artículo científico publicado en 2016

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort

artículo científico publicado en 2015

Targeting the immune system to treat lung cancer: rationale and clinical experience.

artículo científico

The Prognostic Significance of Lymphovascular Invasion on Biopsy Specimens in Lung Cancer Treated With Definitive Chemoradiotherapy ⬇️

artículo científico publicado el 1 de enero de 2012

The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.

artículo científico publicado en 2017

Thermal ablation: tolerance and efficacy in a population mostly composed of primary lung cancers

artículo científico publicado en 2010

Tracheal Glomangioleiomyoma Treated by Multimodal Interventional Bronchoscopy.

artículo científico publicado en 2016

Ultra-sensitive EGFR T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring EGFR del19 Mutations and Treated with First-generation TKIs

scientific article published on 01 April 2019

[A brief overview of a lung cancer biomarker: thymidylate synthase]

artículo científico publicado en 2011

[Adverse effects of new biological therapies for non-small-cell bronchial cancer].

artículo científico publicado en 2011

[An unusual mediastinal mass].

artículo científico publicado en 2013

[COPD and lung cancer: epidemiological and biological links]

artículo científico publicado en 2012

[Efficacy and tolerance of bevacizumab in non-small cell lung cancer: preliminary report]

scientific article published on 01 August 2008

[Introduction to the Thematic Series "Targeted therapies in lung cancers"]

artículo científico publicado en 2014

[New targets and new drugs in thoracic oncology].

artículo científico publicado en 2015

[Socio-anthropological perspective of the under nutrition care of cancer patients]

artículo científico publicado en 2014

[Surgical management and outcomes of lung cancer in women - results from the Epithor database]

artículo científico publicado en 2007

[Which factors influence inclusion of thoracic cancer patients in clinical trials?]

artículo científico publicado en 2014

Lista de obras de Julien Mazieres

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer.

A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.

Alternative Processing of the U2 Small Nuclear RNA Produces a 19–22nt Fragment with Relevance for the Detection of Non-Small Cell Lung Cancer in Human Serum ⬇️

An analysis of treatment delays of thoracic cancers: a prospective study

An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.

Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting.

Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study.

Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.

Bronchial colonisation in patients with lung cancer: a prospective study ⬇️

Bronchoscopic Multimodal Management of Tracheal Neurofibroma

Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung

Characteristics of lung cancer in women: importance of hormonal and growth factors.

Circulating tumor DNA genomics reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant metastatic non-small cell lung cancer patients

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort

Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE

DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients.

Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma

Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls

Diagnostic value of bronchoscopy, CT and transbronchial biopsies in diffuse pulmonary lymphangiomatosis: case report and review of the literature.

Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Erratum to "Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network" [Lung Cancer, 97 (July 2016), 99-104]

Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.

Hospital undertaking of patients with a resection of lung cancer

How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study

Impact of induction treatment on postoperative complications in the treatment of non-small cell lung cancer.

Incidence and characteristics of bronchial colonisation in patient with lung cancer: a retrospective study of 388 cases

Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells.

Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.

Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis

Integration of interventional bronchoscopy in the management of lung cancer

KRAS and bronchial adenocarcinoma. Between disappointments and hopes

Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases

Limited operation for severe multisegmental bilateral bronchiectasis

Loss of RhoB expression in human lung cancer progression.

Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1.

Lung cancer in women and pregnancy: towards a hormonal origin?

Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).

Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP)

Molecular epidemiology of the lung cancer

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.

Nivolumab for treating non-small cell lung cancer.

Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study).

Perception of lung cancer among the general population and comparison with other cancers

Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases.

Prognostic factors associated with interventional bronchoscopy in lung cancer

Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer

RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway

Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: case report and review of the literature.

Radiofrequency ablation of primary lung cancer: a single centre experience

Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial

RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer.

RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition

Routine molecular profiling of patients with NSCLC - Authors' reply

Specificities of lung adenocarcinoma in women who have never smoked.

Stenting for superior vena cava obstruction associated with lung cancer: monocentric study

Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort

Targeting the immune system to treat lung cancer: rationale and clinical experience.

The Prognostic Significance of Lymphovascular Invasion on Biopsy Specimens in Lung Cancer Treated With Definitive Chemoradiotherapy ⬇️

The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.

Thermal ablation: tolerance and efficacy in a population mostly composed of primary lung cancers

Tracheal Glomangioleiomyoma Treated by Multimodal Interventional Bronchoscopy.

Ultra-sensitive EGFR T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring EGFR del19 Mutations and Treated with First-generation TKIs

[A brief overview of a lung cancer biomarker: thymidylate synthase]

[Adverse effects of new biological therapies for non-small-cell bronchial cancer].

[An unusual mediastinal mass].

[COPD and lung cancer: epidemiological and biological links]

[Efficacy and tolerance of bevacizumab in non-small cell lung cancer: preliminary report]

[Introduction to the Thematic Series "Targeted therapies in lung cancers"]